Malakul, Wachirawadee
Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta. [electronic resource]
- Clinical and experimental pharmacology & physiology Feb 2008
- 192-200 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1440-1681
Standard No.: 10.1111/j.1440-1681.2007.04811.x doi
Subjects--Topical Terms: Acetylcholine--pharmacology Animals Aorta, Thoracic--drug effects Apamin--pharmacology Biological Factors--metabolism Blood Glucose--metabolism Body Weight Charybdotoxin--pharmacology Cholesterol--blood Cyclooxygenase Inhibitors--pharmacology Diabetes Mellitus, Experimental--metabolism Diabetes Mellitus, Type 1--metabolism Disease Models, Animal Dose-Response Relationship, Drug Enzyme Inhibitors--pharmacology Guanylate Cyclase--antagonists & inhibitors Hypercholesterolemia--metabolism Indomethacin--pharmacology Male Nitric Oxide--metabolism Nitric Oxide Synthase--antagonists & inhibitors Nitroarginine--pharmacology Nitroprusside--pharmacology Oxadiazoles--pharmacology Oxidative Stress Potassium Channel Blockers--pharmacology Potassium Channels, Calcium-Activated--antagonists & inhibitors Quinoxalines--pharmacology Rats Rats, Sprague-Dawley Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors Soluble Guanylyl Cyclase Superoxides--metabolism Vasodilation--drug effects Vasodilator Agents--pharmacology